Glutathione defense mechanism in liver injury: Insights from animal models

Food and Chemical Toxicology

Volumn 60, Issue , 2013, Pages 38-44

  Chen, Y ^a   Dong, H ^a   Thompson, D C ^a   Shertzer, H G ^b   Nebert, D W ^b   Vasiliou, V ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Glutamate cysteine ligase; Glutathione; Liver injury; Oxidative stress; Steatohepatitis; Steatosis

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CHOLINE; GLUTATHIONE; METHIONINE; PARACETAMOL;

ALCOHOL LIVER DISEASE; DEFENSE MECHANISM; ENZYME ACTIVITY; LIPID DIET; LIVER CELL; LIVER INJURY; LIVER PROTECTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN DEFICIENCY; PROTEIN SYNTHESIS; REVIEW; TRANSGENIC MOUSE;

GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; LIVER INJURY; OXIDATIVE STRESS; STEATOHEPATITIS; STEATOSIS;

ACETAMINOPHEN; ANIMALS; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE DELETION; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HEPATOCYTES; LIVER; MICE; MICE, KNOCKOUT; TETRACHLORODIBENZODIOXIN;

EID: 84881527586     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.07.008     Document Type: Review

References (70)

1. Abdelmegeed M.A., Jang S., Banerjee A., Hardwick J.P., Song B.J. Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury. Free Radic. Biol.Med. 2013, 60:211-222.
2. Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol. Aspects Med. 2008, 29:9-16.
3. Arthur J.R. The glutathione peroxidases. Cell Mol. Life Sci. 2000, 57:1825-1835.
4. Bannai S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 1986, 261:2256-2263.
5. Bentley A.R., Emrani P., Cassano P.A. Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review. Thorax 2008, 63:956-961.
6. Berk M., Johansson S., Wray N.R., Williams L., Olsson C., Haavik J., Bjerkeset O. Glutamate cysteine ligase (GCL) and self reported depression: an association study from the HUNT. J. Affect.Disorders 2011, 131:207-213.
7. Beutler E., Gelbart T., Kondo T., Matsunaga A.T. The molecular basis of a case of gamma-glutamylcysteine synthetase deficiency. Blood 1999, 94:2890-2894.
8. Butticaz C., Gysin R., Cuenod M., Do K.Q. Interaction of GAG trinucleotide repeat and C-129T polymorphisms impairs expression of the glutamate-cysteine ligase catalytic subunit gene. Free Radic. Biol.Med. 2011, 50:617-623.
9. Chen Y., Shertzer H.G., Schneider S.N., Nebert D.W., Dalton T.P. Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J. Biol.Chem. 2005, 280:33766-33774.
10. Chen Y., Yang Y., Miller M.L., Shen D., Shertzer H.G., Stringer K.F., Wang B., Schneider S.N., Nebert D.W., Dalton T.P. Hepatocyte-specific Gclc deletion leads to rapidonset of steatosis with mitochondrial injury and liver failure. Hepatology 2007, 45:1118-1128.
11. Chen Y., Johansson E., Fan Y., Shertzer H.G., Vasiliou V., Nebert D.W., Dalton T.P. Early onset senescence occurs when fibroblasts lack the glutamate-cysteine ligase modifier subunit. Free Radic. Biol.Med. 2009, 47:410-418.
12. Chen Y., Johansson E., Yang Y., Miller M.L., Shen D., Orlicky D.J., Shertzer H.G., Vasiliou V., Nebert D.W., Dalton T.P. Oral N-acetylcysteine rescues lethality ofhepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis. J. Hepatol. 2010, 53:1085-1094.
13. Chen Y., Krishan M., Nebert D.W., Shertzer H.G. Glutathione-deficient mice are susceptible to TCDD-induced hepatocellular toxicity but resistant to steatosis. Chem. Res. Toxicol. 2012, 25:94-100.
14. Dall'Asta V., Gazzola G.C., Franchi-Gazzola R., Bussolati O., Longo N., Guidotti G.G. Pathways of l-glutamic acid transport in cultured human fibroblasts. J. Biol.Chem. 1983, 258:6371-6379.
15. Dalle-Donne I., Rossi R., Giustarini D., Colombo R., Milzani A. S-glutathionylation in protein redox regulation. Free Radic. Biol.Med. 2007, 43:883-898.
16. Dalton T.P., Dieter M.Z., Yang Y., Shertzer H.G., Nebert D.W. Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous. Biochem. Biophys. Res.Commun. 2000, 279:324-329.
17. Dalton T.P., Chen Y., Schneider S.N., Nebert D.W., Shertzer H.G. Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radic. Biol.Med. 2004, 37:1511-1526.
18. Ferret P.J., Hammoud R., Tulliez M., Tran A., Trebeden H., Jaffray P., Malassagne B., Calmus Y., Weill B., Batteux F. Detoxification of reactive oxygen species by anonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 2001, 33:1173-1180.
19. Garcia-Ruiz C., Morales A., Ballesta A., Rodes J., Kaplowitz N., Fernandez-Checa J.C. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J. Clin.Invest. 1994, 94:193-201.
20. Green R.M., Graham M., O'Donovan M.R., Chipman J.K., Hodges N.J. Subcellular compartmentalization of glutathione: correlations with parameters of oxidative stress related togenotoxicity. Mutagenesis 2006, 21:383-390.
21. Griffith O.W., Meister A. Origin and turnover of mitochondrial glutathione. Proc. Natl. Acad. Sci. USA 1985, 82:4668-4672.
22. Gysin R., Kraftsik R., Sandell J., Bovet P., Chappuis C., Conus P., Deppen P., Preisig M., Ruiz V., Steullet P., Tosic M., Werge T., Cuenod M., Do K.Q. Impairedglutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc. Natl. Acad. Sci. USA 2007, 104:16621-16626.
23. Hamilton D., Wu J.H., Alaoui-Jamali M., Batist G. A novel missense mutation in the gamma-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathioneproduction. Blood 2003, 102:725-730.
24. Haque J.A., McMahan R.S., Campbell J.S., Shimizu-Albergine M., Wilson A.M., Botta D., Bammler T.K., Beyer R.P., Montine T.J., Yeh M.M., Kavanagh T.J., Fausto N. Attenuatedprogression of diet-induced steatohepatitis in glutathione-deficient mice. Lab. Invest. 2010, 90:1704-1717.
25. Hogg N. The biochemistry and physiology of S-nitrosothiols. Annu. Rev. Pharmacol. Toxicol. 2002, 42:585-600.
26. Hwang C., Sinskey A.J., Lodish H.F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 1992, 257:1496-1502.
27. Jaeschke H., McGill M.R., Williams C.D., Ramachandran A. Current issues with acetaminophen hepatotoxicity-a clinically relevant model to test the efficacy of natural products. Life Sci. 2011, 88:737-745.
28. Janssen-Heininger Y.M., Mossman B.T., Heintz N.H., Forman H.J., Kalyanaraman B., Finkel T., Stamler J.S., Rhee S.G., van derVliet A. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic. Biol. Med. 2008, 45:1-17.
29. Kendig E.L., Chen Y., Krishan M., Johansson E., Schneider S.N., Genter M.B., Nebert D.W., Shertzer H.G. Lipid metabolism and body composition in Gclm(-/-)mice. Toxicol. Appl. Pharmacol. 2011, 257:338-348.
30. Koide S., Kugiyama K., Sugiyama S., Nakamura S., Fukushima H., Honda O., Yoshimura M., Ogawa H. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardialinfarction. J. Am. Coll. Cardiol. 2003, 41:539-545.
31. Kretzschmar M. Regulation of hepatic glutathione metabolism and its role in hepatotoxicity. Exp. Toxicol. Pathol. 1996, 48:439-446.
32. Lipton A.J., Johnson M.A., Macdonald T., Lieberman M.W., Gozal D., Gaston B. S-nitrosothiols signal the ventilatory response tohypoxia. Nature 2001, 413:171-174.
33. Loh K., Deng H., Fukushima A., Cai X., Boivin B., Galic S., Bruce C., Shields B.J., Skiba B., Ooms L.M., Stepto N., Wu B., Mitchell C.A., Tonks N.K., Watt M.J., Febbraio M.A., Crack P.J., Andrikopoulos S., Tiganis T. Reactiveoxygen species enhance insulin sensitivity. Cell Metab. 2009, 10:260-272.
34. Lu S.C. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 1999, 13:1169-1183.
35. Luthman M., Eriksson S., Holmgren A., Thelander L. Glutathione-dependent hydrogen donor system for calf thymus ribonucleoside-diphosphate reductase. Proc. Natl. Acad. Sci. USA 1979, 76:2158-2162.
36. Mandal P.K., Seiler A., Perisic T., Kolle P., Banjac C.A., Forster H., Weiss N., Kremmer E., Lieberman M.W., Bannai S., Kuhlencordt P., Sato H., Bornkamm G.W., Conrad M. Systemx(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency. J. Biol. Chem. 2010, 285:22244-22253.
37. Matsuzawa-Nagata N., Takamura T., Ando H., Nakamura S., Kurita S., Misu H., Ota T., Yokoyama M., Honda M., Miyamoto K., Kaneko S. Increasedoxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 2008, 57:1071-1077.
38. McConnachie L.A., Mohar I., Hudson F.N., Ware C.B., Ladiges W.C., Fernandez C., Chatterton-Kirchmeier S., White C.C., Pierce R.H., Kavanagh T.J. Glutamate cysteine ligasemodifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice. Toxicol. Sci. 2007, 99:628-636.
39. McConnachie L.A., Botta D., White C.C., Weldy C.S., Wilkerson H.W., Yu J., Dills R., Yu X., Griffith W.C., Faustman E.M., Farin F.M., Gill S.E., Parks W.C., Hu X., Gao X., Eaton D.L., Kavanagh T.J. Theglutathione synthesis gene gclm modulates amphiphilic polymer-coated CdSe/ZnS quantum dot-induced lung inflammation in mice. PLoS One 2013, 8:e64165.
40. Meister A. Metabolism and function of glutathione: an overview. Biochem. Soc. Trans. 1982, 10:78-79.
41. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 1988, 263:17205-17208.
42. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 1991, 51:155-194.
43. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 1983, 52:711-760.
44. Nakamura S., Kugiyama K., Sugiyama S., Miyamoto S., Koide S., Fukushima H., Honda O., Yoshimura M., Ogawa H. Polymorphism in the 5'-flanking region ofhuman glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 2002, 105:2968-2973.
45. Nakamura S., Sugiyama S., Fujioka D., Kawabata K., Ogawa H., Kugiyama K. Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotorfunction. Circulation 2003, 108:1425-1427.
46. Nebert D.W., Puga A., Vasiliou V. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. N.Y. Acad. Sci. 1993, 685:624-640.
47. Nichenametla S.N., Lazarus P., Richie J.P. A GAG trinucleotide-repeat polymorphism in the gene for glutathione biosynthetic enzyme, GCLC, affects gene expression through translation. FASEB J. 2011, 25:2180-2187.
48. Nichenametla S.N., Muscat J.E., Liao J.G., Lazarus P., Richie J.P. A functional trinucleotide repeat polymorphism in the 5'-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers. Mol.Carcinogen. 2012, May 18. [Epub ahead of print].
49. Njalsson R., Norgren S. Physiological and pathological aspects of GSH metabolism. Acta Paediatr. 2005, 94:132-137.
50. O'Brian C.A., Chu F. Post-translational disulfide modifications in cell signaling-role of inter-protein, intra-protein, S-glutathionyl, and S-cysteaminyl disulfide modifications in signal transmission. Free Radic. Res. 2005, 39:471-480.
51. Pessayre D., Mansouri A., Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am. J. Phys. Gastrointest. Liver Phys. 2002, 282:G193-G199.
52. Pessayre D., Fromenty B., Mansouri A. Mitochondrial injury in steatohepatitis. Eur. J. Gastroenterol. Hepatol. 2004, 16:1095-1105.
53. Pessayre D., Fromenty B., Berson A., Robin M.A., Letteron P., Moreau R., Mansouri A. Central role of mitochondria in drug-induced liver injury. Drug Metab.Rev. 2012, 44:34-87.
54. Pompella A., Visvikis A., Paolicchi A., De Tata V., Casini A.F. The changing faces of glutathione, a cellular protagonist. Biochem.Pharmacol. 2003, 66:1499-1503.
55. Richman P.G., Meister A. Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione. J. Biol. Chem. 1975, 250:1422-1426.
56. Rinaldi R., Eliasson E., Swedmark S., Morgenstern R. Reactive intermediates and the dynamics of glutathione transferases. Drug Metab Dispos. 2002, 30:1053-1058.
57. Rinella M.E., Elias M.S., Smolak R.R., Fu T., Borensztajn J., Green R.M. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J. LipidRes. 2008, 49:1068-1076.
58. Ristoff E., Larsson A. Patients with genetic defects in the gamma-glutamyl cycle. Chem. Biol. Interact. 1998, 111-112:113-121.
59. Ristoff E., Augustson C., Geissler J., de Rijk T., Carlsson K., Luo J.L., Andersson K., Weening R.S., vanZwieten R., Larsson A., Roos D. A missense mutation in the heavy subunit of gamma-glutamylcysteine synthetase gene causes hemolytic anemia. Blood 2000, 95:2193-2196.
60. Shen D., Dalton T.P., Nebert D.W., Shertzer H.G. Glutathione redox state regulates mitochondrial reactive oxygen production. J. Biol. Chem. 2005, 280:25305-25312.
61. Shertzer H.G., Clay C.D., Genter M.B., Chames M.C., Schneider S.N., Oakley G.G., Nebert D.W., Dalton T.P. Uncoupling-mediated generation of reactive oxygen by halogenated aromatic hydrocarbons in mouse livermicrosomes. Free Radic. Biol. Med. 2004, 36:618-631.
62. Shi Z.Z., Osei-Frimpong J., Kala G., Kala S.V., Barrios R.J., Habib G.M., Lukin D.J., Danney C.M., Matzuk M.M., Lieberman M.W. Glutathione synthesis is essential for mousedevelopment but not for cell growth in culture. Proc. Natl. Acad. Sci. USA 2000, 97:5101-5106.
63. Sjodin K., Nilsson E., Hallberg A., Tunek A. Metabolism of N-acetyl-L-cysteine. Some structural requirements for the deacetylation and consequences for the oral bioavailability. Biochem. Pharmacol. 1989, 38:3981-3985.
64. Taylor C.G., Nagy L.E., Bray T.M. Nutritional and hormonal regulation of glutathione homeostasis. Curr. Top. Cell. Regul. 1996, 34:189-208.
65. Toppo S., Flohe L., Ursini F., Vanin S., Maiorino M. Catalytic mechanisms and specificities of glutathione peroxidases: variations of a basic scheme. Biochim. Biophys.Acta 2009, 1790:1486-1500.
66. Tosic M., Ott J., Barral S., Bovet P., Deppen P., Gheorghita F., Matthey M.L., Parnas J., Preisig M., Saraga M., Solida A., Timm S., Wang A.G., Werge T., Cuenod M., Do K.Q. Schizophreniaand oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am. J. Hum. Genet. 2006, 79:586-592.
67. Vetelainen R., van V.A., van Gulik T.M. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J. Gastroenterol. Hepatol. 2007, 22:1526-1533.
68. Villeneuve J.P., Pichette V. Cytochrome P450 and liver diseases. Curr. Drug Metab. 2004, 5:273-282.
69. Yang Y., Dieter M.Z., Chen Y., Shertzer H.G., Nebert D.W., Dalton T.P. Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J. Biol.Chem. 2002, 277:49446-49452.
70. Yoo S.E., Chen L., Na R., Liu Y., Rios C., Van R.H., Richardson A., Ran Q. Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss inbrain. Free Radic. Biol. Med. 2012, 52:1820-1827.